How LadyCare Works
LadyCare relieves menopausal symptoms for 71% of women by helping to rebalance part of the Autonomic Nervous System (ANS).
The technology helps by reducing excessive sympathetic nervous system (SNS) activity and increasing parasympathetic activity, thus restoring equilibrium and creating a healthier balance between the two parts of the ANS.
About the Autonomic Nervous System (ANS)
When a woman reaches the life stage of menopause or experiences an early menopause due to surgery (hysterectomy), it is normal for a high percentage to suffer with a number of unpleasant and uncomfortable symptoms. These life-changing symptoms can be so pronounced that many women feel the only way to suppress them is with hormone replacement therapy (HRT).
Menopause symptoms are the result of a natural reduction of hormones, primarily progesterone and oestrogens. These reductions cause an imbalance to the Autonomic Nervous System (ANS), which is responsible for controlling bodily functions, including stress reactions such as sweating, body temperature, circulation, heart rate, bowel and bladder function, and more.
There are two divisions of the ANS, the Sympathetic Nervous system (SNS) and the Parasympathetic Nervous System (PNS). Symptoms such as sweating and anxiety, which are commonly associated with menopause, are under the control of the Sympathetic division, which is our body’s fight-flight stress reactor system. For example, when we perceive a threat, this is the system that causes our heart to beat faster and our pupils to dilate to allow more light for enhanced visual acuity and faster reactions.
In contrast, the Parasympathetic division (PNS) is responsible for REST and DIGESTION. This is the body’s repair and regulatory system and it tends to have the opposite effect to the SNS. For example, the SNS speeds the heart rate while the PNS slows it down. The two systems work together to regulate all of our organ systems.
Research conducted on LadyCare by Dr. Nyjon Eccles (2011) with the British Women Police using a heart rate variability machine enabled us to elucidate its mechanism of action in alleviating menopause symptoms. The initial testing, prior to the use of LadyCare, confirmed that all the women suffering with hot sweats had an imbalance of their ANS.
Within one month of using the LadyCare device 71% were no longer suffering with hot sweats. Further testing with the heart rate variability monitor showed that the women’s Autonomic Nervous Systems had also been rebalanced. In other words, their ANS excess was reduced while their PNS activity was increased, thereby generating a healthier, balanced state of equilibrium between the two parts of the ANS.
Hundreds of thousands of women worldwide are now using LadyCare with success having decided for many reasons to stop taking HRT. We always recommend LadyCare should be used for at least two weeks before gradually reducing HRT.